95 related articles for article (PubMed ID: 12047971)
1. Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test.
Anetseder M; Hager M; Müller CR; Roewer N
Lancet; 2002 May; 359(9317):1579-80. PubMed ID: 12047971
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individuals.
Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
Eur J Anaesthesiol; 2010 Jan; 27(1):77-82. PubMed ID: 19809329
[TBL] [Abstract][Full Text] [Related]
3. A minimally invasive metabolic test with intramuscular injection of halothane 5 and 6 vol% to detect probands at risk for malignant hyperthermia.
Schuster F; Gardill A; Metterlein T; Kranke P; Roewer N; Anetseder M
Anaesthesia; 2007 Sep; 62(9):882-7. PubMed ID: 17697213
[TBL] [Abstract][Full Text] [Related]
4. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M
Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904
[TBL] [Abstract][Full Text] [Related]
5. Regional lactate and carbon dioxide concentrations in a metabolic test for malignant hyperthermia.
Anetseder M; Hager M; Müller-Reible C; Roewer N
Lancet; 2003 Aug; 362(9382):494; discussion 494-5. PubMed ID: 12927444
[No Abstract] [Full Text] [Related]
6. Effects of ryanodine on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
Bina S; Muldoon S; Bünger R
Eur J Anaesthesiol; 2008 Jan; 25(1):48-57. PubMed ID: 17686208
[TBL] [Abstract][Full Text] [Related]
7. Screening test for malignant hyperthermia in patients with persistent hyperCKemia: a pilot study.
Johannsen S; Berberich C; Metterlein T; Roth C; Reiners K; Roewer N; Schuster F
Muscle Nerve; 2013 May; 47(5):677-81. PubMed ID: 23400941
[TBL] [Abstract][Full Text] [Related]
8. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
9. The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.
Schuster F; Schöll H; Hager M; Müller R; Roewer N; Anetseder M
Anesth Analg; 2006 Feb; 102(2):468-72. PubMed ID: 16428544
[TBL] [Abstract][Full Text] [Related]
10. Caffeine impairs intramuscular energy balance in patients susceptible to malignant hyperthermia.
Textor Z; Beer M; Anetseder M; Köstler H; Kagerbauer E; Kenn W; Hahn D; Roewer N
Muscle Nerve; 2003 Sep; 28(3):353-8. PubMed ID: 12929196
[TBL] [Abstract][Full Text] [Related]
11. [In-vivo diagnosis of malignant hyperthermia susceptibility: a microdialysis study].
Schuster F; Hager M; Metterlein T; Muellenbach RM; Wurmb T; Wunder C; Roewer N; Anetseder M
Anaesthesist; 2008 Aug; 57(8):767-74. PubMed ID: 18563374
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].
Urwyler A; Censier K; Seeberger MD; Drewe J; Rothenbühler JM; Frei F
Schweiz Med Wochenschr; 1991 Apr; 121(16):566-71. PubMed ID: 2042040
[TBL] [Abstract][Full Text] [Related]
13. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group.
Larach MG
Anesth Analg; 1989 Oct; 69(4):511-5. PubMed ID: 2675676
[No Abstract] [Full Text] [Related]
14. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
[TBL] [Abstract][Full Text] [Related]
15. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
[TBL] [Abstract][Full Text] [Related]
16. Is resting membrane potential a possible indicator of viability of muscle bundles used in the in vitro caffeine contracture test?
Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyford HG; Dupuis BA
Anesth Analg; 1992 Jan; 74(1):105-11. PubMed ID: 1734769
[TBL] [Abstract][Full Text] [Related]
17. Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study.
Metterlein T; Hartung E; Schuster F; Roewer N; Anetseder M
Minerva Anestesiol; 2011 Aug; 77(8):768-73. PubMed ID: 21730923
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of susceptibility to malignant hyperthermia in children].
Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
[TBL] [Abstract][Full Text] [Related]
19. [High purity ryanodine for in vitro diagnosis of malignant hyperthermia].
Wappler F; Roewer N; Lenzen C; Scholz J; Steinfath M; Rumberger R; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Nov; 28(7):427-31. PubMed ID: 8297948
[TBL] [Abstract][Full Text] [Related]
20. [In vitro caffeine test on skeletal muscle samples from swine].
Rösel U; Szentkuti L
Dtsch Tierarztl Wochenschr; 1993 Jan; 100(1):25-8. PubMed ID: 8428567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]